Phase 2 Study of TAT4 Gel for Reduction of Nasolabial Folds

Status unconfirmed · Phase 2 · Has a placebo group

Conditions studied: Nasolabial Folds

In brief

This is a Phase 2, randomized, double-blind, placebo-controlled study of TAT4 Gel for the reduction of moderate to severe nasolabial folds.

Key facts

Study ID

NCT02607670

Run by

Topokine Therapeutics, Inc.

People needed

111

Starts

2016-01-01

Expected to finish

2016-09-01

Last updated by the study team

2016-01-05

Who can join

Age: 35 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Moderate to severe, bilateral nasolabial folds
• Must understand and provide informed consent

You may not qualify if…

• Pregnant or lactating women
• History of skin hypersensitivity of atopic dermatitis
• Any illness of disease that, in the investigator's opinion, would make trial participation inadvisable

Where it is running

• Topokine Research Site — Boston, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.